C
COMPASS Pathways plc (CMPS)
NMS – Real vaqt narxi. Valyuta: USD
9.37
-0.28 (-2.90%)
Yopilishda: May 12, 2026, 4:00 PM EDT
9.49
+0.12 (1.32%)
Bozordan keyin: May 12, 2026, 7:59 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NMS – Real vaqt narxi. Valyuta: USD
9.37
-0.28 (-2.90%)
Yopilishda: May 12, 2026, 4:00 PM EDT
9.49
+0.12 (1.32%)
Bozordan keyin: May 12, 2026, 7:59 PM EDT
COMPASS Pathways plc Buyuk Britaniya va AQShda ruhiy salomatlikka e'tibor qaratgan biotexnologiya kompaniyasi sifatida faoliyat yuritadi. Kompaniya COMP360, psilotsibin terapiyasini ishlab chiqadi, bu davolashga chidamli depressiyani davolash uchun III bosqich klinik sinovdan o'tmoqda; va post-travmatik stress buzilishi va anoreksiya nervozini davolash uchun II bosqich klinik sinovda. Kompaniya ilgari COMPASS Rx Limited nomi bilan tanilgan va 2020-yil avgust oyida COMPASS Pathways plc nomini o'zgartirgan. Kompaniya 2020-yilda tashkil etilgan va Buyuk Britaniyaning London shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Guy Goodwin | Chief Medical Officer |
| Dr. Michael Gold M.D., M.Sc. | Chief Research & Development Officer |
| Dr. Steve Levine M.D. | Chief Patient Officer |
| Dr. Susan C. Stansfield Ph.D. | Advisor |
| Mr. Benjamin Harber | Company Secretary |
| Mr. Kabir Kumar Nath M.A., M.B.A. | CEO & Director |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-04-15 | DEF 14A | d87237ddef14a.htm |
| 2026-03-24 | S-8 | compass-sx82026inducementp.htm |
| 2026-03-24 | 10-K | cmps-20251231.htm |
| 2026-02-19 | 8-K | cmps-20260218.htm |
| 2026-02-17 | 8-K | cmps-20260217.htm |
| 2026-01-07 | 8-K | cmps-20260105.htm |
| 2025-11-04 | 8-K | cmps-20251104.htm |
| 2025-10-29 | 8-K | cmps-20251026.htm |
| 2025-07-31 | 8-K | cmps-20250731.htm |
| 2025-07-29 | 8-K | cmps-20250728.htm |
| Mr. Lars Christian Wilde | Senior Advisor |
| Mr. Stephen D. Schultz | Senior Vice President of Investor Relations |
| Ms. Lori Englebert M.B.A. | Chief Commercial Officer |
| Ms. Teri Loxam M.B.A. | Chief Financial Officer |